Identification of the key role of IL-17RB in the treatment of osteoarthritis with Shaoyao Gancao decoction: Verification based on RNA-seq and bioinformatics analysis.

<h4>Background</h4>Shaoyao Gancao Decoction (SGD) is a classic and representative oral administration of traditional Chinese medicine formula. It is composed of two Chinese herbal medicines, Paeoniae Radix Alba [Paeonia lactiflora Pall] and Glycyrrhizae Radix et Rhizoma. The clinical stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Chengzhi Hou, Zhangjingze Yu, Qinghui Song, Xuelei Chu, Guangcheng Wei, Jia Zhu, Liping Yang, Yong Zhao, Ping Zhang, Qiuyue Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0315913
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849323350026878976
author Chengzhi Hou
Zhangjingze Yu
Qinghui Song
Xuelei Chu
Guangcheng Wei
Jia Zhu
Liping Yang
Yong Zhao
Ping Zhang
Qiuyue Li
author_facet Chengzhi Hou
Zhangjingze Yu
Qinghui Song
Xuelei Chu
Guangcheng Wei
Jia Zhu
Liping Yang
Yong Zhao
Ping Zhang
Qiuyue Li
author_sort Chengzhi Hou
collection DOAJ
description <h4>Background</h4>Shaoyao Gancao Decoction (SGD) is a classic and representative oral administration of traditional Chinese medicine formula. It is composed of two Chinese herbal medicines, Paeoniae Radix Alba [Paeonia lactiflora Pall] and Glycyrrhizae Radix et Rhizoma. The clinical study found SGD could effectively reduce clinical symptoms and improve the level of inflammation in osteoarthritis (OA) patients.<h4>Purpose</h4>The aim of this study is to identify the efficacy and molecular mechanism of SGD in the treatment of OA, and find the new therapeutic target through RNA sequencing (RNA-Seq) to provide theoretical support for its clinical application.<h4>Methods</h4>Destabilization of the medial meniscus (DMM) OA rat model was established in vivo. Hematoxylineosin staining, safranin O/fast green staining and immunohistochemistry were used to observe changes of cartilage Histology and extracellular matrix (ECM) of cartilage cells. In vitro, the chondrocyte-like cells were derived from ATDC5 cells and induced by interleukin-1 beta to establish the model. The medial meniscotibial ligament (MTT) test was used to identify the effects of SGD on chondrocyte-like cell proliferation, and immunocytochemistry was used to assess changes in chondrocyte ECM. The differentially expressed genes (DEGs) were obtained by RNA-Seq. Meanwhile, the core targets were found through bioinformatics analysis, and then verified by qRT-PCR and Western Blotting. The inflammatory factors IL-1β, IL-6 and TNF-α were detected by ELISA.<h4>Results</h4>SGD could alleviate cartilage degeneration, and reduce ECM degradation in OA by upregulating COL2A1 and downregulating MMP-13. 120 key targets were screened from DEGs by RNA-Seq. Based on further bioinformatics analysis, interleukin 17 receptor B (IL-17RB), interleukin 23 receptor and growth differentiation factor 5 were finally selected as core targets. IL-17RB has rarely been reported in previous studies about OA, and worthy of further study. Subsequently, it was found that the gene and protein expressions of IL-17RB were significantly reversed in model group after SGD treatment. Moreover, SGD could inhibit the release of inflammatory factors by mediating IL-17RB in OA.<h4>Conclusions</h4>SGD reduced the release of inflammatory factors IL-1β, IL-6 and TNF-α, upregulated COL2A1 and downregulated MMP-13 to alleviate degradation of ECM, and reduced the cartilage degeneration and progression of OA by reducing IL-17RB in articular cartilage.
format Article
id doaj-art-e06ee772db2d4266b32dc40fa36f3475
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-e06ee772db2d4266b32dc40fa36f34752025-08-20T03:49:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01202e031591310.1371/journal.pone.0315913Identification of the key role of IL-17RB in the treatment of osteoarthritis with Shaoyao Gancao decoction: Verification based on RNA-seq and bioinformatics analysis.Chengzhi HouZhangjingze YuQinghui SongXuelei ChuGuangcheng WeiJia ZhuLiping YangYong ZhaoPing ZhangQiuyue Li<h4>Background</h4>Shaoyao Gancao Decoction (SGD) is a classic and representative oral administration of traditional Chinese medicine formula. It is composed of two Chinese herbal medicines, Paeoniae Radix Alba [Paeonia lactiflora Pall] and Glycyrrhizae Radix et Rhizoma. The clinical study found SGD could effectively reduce clinical symptoms and improve the level of inflammation in osteoarthritis (OA) patients.<h4>Purpose</h4>The aim of this study is to identify the efficacy and molecular mechanism of SGD in the treatment of OA, and find the new therapeutic target through RNA sequencing (RNA-Seq) to provide theoretical support for its clinical application.<h4>Methods</h4>Destabilization of the medial meniscus (DMM) OA rat model was established in vivo. Hematoxylineosin staining, safranin O/fast green staining and immunohistochemistry were used to observe changes of cartilage Histology and extracellular matrix (ECM) of cartilage cells. In vitro, the chondrocyte-like cells were derived from ATDC5 cells and induced by interleukin-1 beta to establish the model. The medial meniscotibial ligament (MTT) test was used to identify the effects of SGD on chondrocyte-like cell proliferation, and immunocytochemistry was used to assess changes in chondrocyte ECM. The differentially expressed genes (DEGs) were obtained by RNA-Seq. Meanwhile, the core targets were found through bioinformatics analysis, and then verified by qRT-PCR and Western Blotting. The inflammatory factors IL-1β, IL-6 and TNF-α were detected by ELISA.<h4>Results</h4>SGD could alleviate cartilage degeneration, and reduce ECM degradation in OA by upregulating COL2A1 and downregulating MMP-13. 120 key targets were screened from DEGs by RNA-Seq. Based on further bioinformatics analysis, interleukin 17 receptor B (IL-17RB), interleukin 23 receptor and growth differentiation factor 5 were finally selected as core targets. IL-17RB has rarely been reported in previous studies about OA, and worthy of further study. Subsequently, it was found that the gene and protein expressions of IL-17RB were significantly reversed in model group after SGD treatment. Moreover, SGD could inhibit the release of inflammatory factors by mediating IL-17RB in OA.<h4>Conclusions</h4>SGD reduced the release of inflammatory factors IL-1β, IL-6 and TNF-α, upregulated COL2A1 and downregulated MMP-13 to alleviate degradation of ECM, and reduced the cartilage degeneration and progression of OA by reducing IL-17RB in articular cartilage.https://doi.org/10.1371/journal.pone.0315913
spellingShingle Chengzhi Hou
Zhangjingze Yu
Qinghui Song
Xuelei Chu
Guangcheng Wei
Jia Zhu
Liping Yang
Yong Zhao
Ping Zhang
Qiuyue Li
Identification of the key role of IL-17RB in the treatment of osteoarthritis with Shaoyao Gancao decoction: Verification based on RNA-seq and bioinformatics analysis.
PLoS ONE
title Identification of the key role of IL-17RB in the treatment of osteoarthritis with Shaoyao Gancao decoction: Verification based on RNA-seq and bioinformatics analysis.
title_full Identification of the key role of IL-17RB in the treatment of osteoarthritis with Shaoyao Gancao decoction: Verification based on RNA-seq and bioinformatics analysis.
title_fullStr Identification of the key role of IL-17RB in the treatment of osteoarthritis with Shaoyao Gancao decoction: Verification based on RNA-seq and bioinformatics analysis.
title_full_unstemmed Identification of the key role of IL-17RB in the treatment of osteoarthritis with Shaoyao Gancao decoction: Verification based on RNA-seq and bioinformatics analysis.
title_short Identification of the key role of IL-17RB in the treatment of osteoarthritis with Shaoyao Gancao decoction: Verification based on RNA-seq and bioinformatics analysis.
title_sort identification of the key role of il 17rb in the treatment of osteoarthritis with shaoyao gancao decoction verification based on rna seq and bioinformatics analysis
url https://doi.org/10.1371/journal.pone.0315913
work_keys_str_mv AT chengzhihou identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis
AT zhangjingzeyu identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis
AT qinghuisong identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis
AT xueleichu identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis
AT guangchengwei identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis
AT jiazhu identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis
AT lipingyang identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis
AT yongzhao identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis
AT pingzhang identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis
AT qiuyueli identificationofthekeyroleofil17rbinthetreatmentofosteoarthritiswithshaoyaogancaodecoctionverificationbasedonrnaseqandbioinformaticsanalysis